Adverse Events Following Short-Course Systemic Corticosteroids Among Children and Adolescents
Unerwünschte Ereignisse nach kurzfristiger systemischer Kortikosteroidgabe bei Kindern und Jugendlichen
JAMA Network Open · 30.09.2025 · 8 (9) · e2534953
DOI: 10.1001/jamanetworkopen.2025.34953 ↗Auf einen Blick
45 Studien mit 6470 Kindern und Jugendlichen: Kurzzeitige systemische Kortikosteroide waren mit mehr Hyperglykämien und Schlafproblemen verbunden. Schwere unerwünschte Ereignisse waren selten.
Fragestellung
Welche unerwünschten Ereignisse sind bei Kindern und Jugendlichen nach einer kurzfristigen systemischen Kortikosteroidgabe assoziiert?
Methode
Systematische Übersicht und Metaanalyse randomisierter Studien; Suche in MEDLINE, Embase und CENTRAL bis Februar 2025; Bewertung mit GRADE.
Ergebnisse
45 RCTs mit 6470 Kindern. Keine Assoziation mit schweren AE, Abbruch wegen AE oder Verhaltensänderung. Erhöhtes Risiko für Hyperglykämie (RD 38/1000; 95 %-KI 11 bis 64), Schlafprobleme (RD 15/1000; 95 %-KI 1 bis 28) und GI-Blutung (RD 13/1000; 95 %-KI 3 bis 23; niedrige Sicherheit).
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass Kortikosteroide mit einem erhöhten Risiko für Hyperglykämie und Schlafprobleme assoziiert waren; diese AE waren sehr selten schwer. Weitere Forschung sei nötig.
Kernaussagen
- Hyperglykämie: RD 38/1000; 95 %-KI 11 bis 64
- Schlafprobleme: RD 15/1000; 95 %-KI 1 bis 28
- Schwere AE waren nicht erhöht; GI-Blutung mit niedriger Sicherheit
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 30.09.2025. Verfasst von João Pedro Lima und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit, Kinderkrankenpflege
Abstract (Originalsprache)
Importance Short courses of systemic corticosteroids are used in the management of a number of acute clinical conditions, including Bell palsy, croup, and pneumonia, but research on associations of corticosteroid use with adverse events (AEs) in children is limited.
Objective
To document AEs associated with short-term (≤14 days) use of systemic corticosteroids in children and adolescents (1 to younger than 18 years) across different clinical conditions. Data Sources MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched from inception to February 2025. Reference lists of eligible articles and related systematic reviews were also searched. Study Selection Randomized clinical trials evaluating AEs (any unfavorable and unintended signs, symptoms, or syndromes that occurred during the period of using an investigational product) after use of short-course systemic corticosteroids in children and adolescents were included. Data Extraction and Synthesis Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline, pairs of reviewers independently reviewed abstracts, extracted data, and assessed risk of bias of eligible trials. Pairwise, fixed-effects meta-analyses were performed using Mantel-Haenszel methods with risk difference (RD). Main Outcomes and Measures The primary outcomes were serious AEs (events resulting in death, life-threatening conditions, hospitalization, or substantial disability), AEs leading to discontinuation, hyperglycemia, sleep disturbances, change in behavior, and gastrointestinal bleeding. RDs were reported as AEs per 1000 patients with 95% CIs. The Grading of Recommendations Assessment, Development and Evaluation approach was used to assess the certainty of evidence (high, moderate, low, or very low certainty).
Results
A total of 45 eligible trials that included 6470 children (mean [SD] age, 5.57 [3.62] years; 3753 male [58%]) were identified. In pooled analysis, there was moderate certainty evidence that compared with usual care, corticosteroids were not associated with serious AEs (RD, 1 fewer AE per 1000 patients [95% CI], 9 fewer to 7 more AEs per 1000 patients]), AEs leading to discontinuation (RD, 4 more AEs per 1000 patients [95% CI, 3 fewer to 11 more AEs per 1000 patients]), or change in behavior (RD, 8 more AEs per 1000 patients [95% CI, 5 fewer to 21 more AEs per 1000 patients]). With moderate certainty evidence, corticosteroids were associated with an increased risk of hyperglycemia (RD, 38 more AEs per 1000 patients [95% CI, 11 to 64 more AEs per 1000 patients]) and sleep problems (RD, 15 more AEs per 1000 patients [95% CI, 1 to 28 more AEs per 1000 patients]). Corticosteroid use was also associated with an increased risk of gastrointestinal bleeding (RD, 13 more per AEs per 1000 patients [95% CI, 3 to 23 more AEs per 1000 patients]), but the certainty of evidence was low. Conclusions and Relevance In this systematic review and meta-analysis of randomized trials, there was moderate certainty evidence that corticosteroids were associated with an increased risk of hyperglycemia and sleep problems and low certainty evidence that corticosteroids were associated with increased risk of gastrointestinal bleeding, but these AEs were very seldom serious. These findings suggest that an individualized approach to short-term corticosteroid use may be warranted and that further research is needed to obtain better quality of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
- Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.
- Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.
- Department of Cardiology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, China.
- Department of Public Health, North South University, Dhaka, Bangladesh.
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Zitieren
APA
Lima, J. P., Chowdhury, S. R., Tangamornsuksan, W., Zhai, C., Chu, X., Matos Silva, J., Kabir, H., Chowdhury, M. R., Couban, R., Walsh, M., Rochwerg, B., Eltorki, M., Guyatt, G. H., & Chu, D. (2025). Adverse Events Following Short-Course Systemic Corticosteroids Among Children and Adolescents. JAMA Network Open, 8(9), e2534953. https://doi.org/10.1001/jamanetworkopen.2025.34953
Vancouver
Lima JP, Chowdhury SR, Tangamornsuksan W, Zhai C, Chu X, Matos Silva J, et al. Adverse Events Following Short-Course Systemic Corticosteroids Among Children and Adolescents. JAMA Network Open. 2025;8(9):e2534953. doi:10.1001/jamanetworkopen.2025.34953
BibTeX
@article{Lima2025,
author = {Lima, João Pedro and Chowdhury, Saifur R and Tangamornsuksan, Wimonchat and Zhai, Chunjuan and Chu, Xiajing and Matos Silva, Jessyca and Kabir, Humayun and Chowdhury, Mahmudur Rahman and Couban, Rachel and Walsh, Michael and Rochwerg, Bram and Eltorki, Mohamed and Guyatt, Gordon H and Chu, Derek},
title = {Adverse Events Following Short-Course Systemic Corticosteroids Among Children and Adolescents},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {9},
pages = {e2534953},
doi = {10.1001/jamanetworkopen.2025.34953}
}
EUVIMED